I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO

Forschungsprojekte

• NEUROendocrine SENSor for Sudden Unexpected Death in Epilepsy (SUDEP) prediction and prevention NEUROSENSE proposes a novel and visionary technology resulting from the demonstration of the upstream role of…
• Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease Crohn’s disease is a non-communicable, global disease with an accelerating incidence (up to 23 per 100,000 pe…
• A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to treat knee osteoarthritis According to the WHO Osteoarthritis (OA) is one major course of years lived with disability in the elderly an…
• Photosynthetic electron focusing technology for direct efficient biohydrogen production from solar energy We propose a disruptive technology based on synthetic biology, we call photosynthetic electron focusing, for…
• Improving GreeN Innovation for the blue revoluTION: new tools and opportunities for a more sustainable animal farming Animal health and welfare are issues of high research priority for European aquaculture. In particular, impro…
• CArdiovascularREsolution of INflammation to promote HEALTH With 1.9 million deaths and an economic burden estimated to €200 billion each year in Europe, cardiovascular…
• GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION Chronic inflammation underlies several diseases. In Crohn´s disease (CD), there is mounting evidence of a pre…
• An Artificially Intelligent Diagnostic Assistant for gastric inflammation Most cases of gastric cancer (GC) are detected at a late stage, when patients have a median life expectancy o…
• REMODELLING OF THE INFARCTED HEART: PIEZOELECTRIC MULTIFUNCTIONAL PATCH ENABLING THE SEQUENTIAL RELEASE OF THERAPEUTIC FACTORS Cardiac disease remains a major societal and healthcare burden that affect nearly two million European citize…
• CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heri…
• Glycans as Master Switches of B Cell Activity in Autoimmunity Autoimmune diseases including rheumatoid arthritis (RA) are often life-threatening disorders with increasing…
• Blood as energy source to power smart cardiac devices Cardiovascular diseases (CVD) are the leading cause of death globally, taking 18.6M lives/yr. Most CVD are as…